Background Breast cancer care has been affected by the COVID-19 pandemic. This
systematic review aims to describe the observed pandemic-related changes in clinical and …

Background Cancer comprises a high burden on health systems. Performance indicators
monitoring cancer outcomes are routinely used in OECD countries. However, the …

Importance Several studies reported sharp decreases in screening mammography for breast
cancer and low-dose computed tomographic screening for lung cancer in the early months …

Objectives We explore the routes to cancer diagnosis to further undertanding of the
inequality in the reduction in detection of new cancers since the start of the pandemic. We …

Background Several countries have reported a decline in cancer diagnoses during the
COVID-19 pandemic [Citation 1–7]. The European Cancer Organisation estimated that …

Introduction The COVID-19 pandemic had collateral effects on many health systems. Cancer
screening and diagnostic tests were postponed, resulting in delays in diagnosis and …

Simple Summary Concerns about potential diagnostic delays due to pandemic-related
disruptions were expressed early during the COVID-19 outbreak. In the present study, we …

The severity of the COVID‐19 pandemic and subsequent mitigation strategies have varied
across the Nordic countries. In a joint Nordic population‐based effort, we compared patterns …

Background This study aimed to estimate potential undetected cancers over the first 2 years
of the COVID-19 pandemic in Catalonia. Methods Cancer incidence was compared between …

Background The emergence of COVID-19 disrupted health care, with consequences for
cancer diagnoses and outcomes, especially for early stage diagnoses, which generally have …